EUVIMEDEUVIMED entdecken
Crossref

Potential Benefits of Statin Therapy in Reducing Osteoarthritis Risk: A Mendelian Randomization Study

Lili Zhang, Laijian Sui, Jing Li, Rui Zhang, Weimin Pan, Teng Lv iD

Arthritis Care & Research · 2024

DOI: 10.1002/acr.25343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Lili Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Genome-Wide Association Study, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of this study was to determine the causal effect of statins on osteoarthritis (OA) risk using Mendelian randomization (MR).

Methods

Single nucleotide polymorphism–based genome‐wide association analyses of statins were collected from the UK Biobank and FinnGen dataset, and OA data were collected from the UK Biobank and Arthritis Research UK Osteoarthritis Genetics (arcOGEN) study. Two‐sample MR analyses were performed using the inverse‐variance weighted (IVW) technique. MR‐Egger, weighted median, and weighted mode served as supplementary analyses. MR‐Egger regression, Cochran's Q test, and Mendelian Randomization Pleiotropy Residual Sum and Outlier analysis were performed as sensitivity analyses. Hydroxymethylglutaryl‐coenzyme A reductase (HMGCR) expression and OA risk were evaluated using summary data–based MR (SMR).

Results

MR analyses consistently supported a causal connection between statin use and OA risk. A causal effect was observed for atorvastatin (IVW: β = −2.989, P = 0.003) and rosuvastatin (IVW: β = −14.141, P = 0.006) treatment on hip OA. Meta‐analysis showed the association between atorvastatin and knee OA was statistically significant (odds ratio 0.15; P = 0.004). Simvastatin use exhibited a protective effect against knee (IVW: β = −1.056, P = 0.004) and hip OA (IVW: β = −1.405, P = 0.001). Statin medication showed a protective effect on hip OA (IVW: β = −0.054, P = 0.013). HMGCR correlated significantly with a reduced risk of knee OA (β = −0.193, P SMR = 0.017), rather than hip OA (β = 0.067, P SMR = 0.502), which suggested that statins' protective effect on OA may not be related to its lipid‐lowering effect.

Conclusion

This MR study provides compelling evidence that statin treatment may be a protective factor for OA. Further research is required to clarify its underlying mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisHydroxymethylglutaryl-CoA Reductase InhibitorsGenome-Wide Association StudyPolymorphism, Single NucleotideHumansOsteoarthritis, HipOsteoarthritis, KneeRisk FactorsHydroxymethylglutaryl CoA ReductasesRisk AssessmentMaleOsteoarthritisFemaleProtective FactorsRosuvastatin CalciumMiddle Aged

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsHydroxymethylglutaryl CoA ReductasesHMGCR protein, humanRosuvastatin Calcium

Autor:innen und Institutionen

  • The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Yantai Yuhuangding Hospital, Yantai, China.

ORCID-Profile: Teng Lv

Zitieren

APA

Zhang, L., Sui, L., Li, J., Zhang, R., Pan, W., & Lv, T. (2024). Potential Benefits of Statin Therapy in Reducing Osteoarthritis Risk: A Mendelian Randomization Study. Arthritis Care & Research. https://doi.org/10.1002/acr.25343

Vancouver

Zhang L, Sui L, Li J, Zhang R, Pan W, Lv T. Potential Benefits of Statin Therapy in Reducing Osteoarthritis Risk: A Mendelian Randomization Study. Arthritis Care & Research. 2024. doi:10.1002/acr.25343

BibTeX
@article{Zhang2024,
  author = {Zhang, Lili and Sui, Laijian and Li, Jing and Zhang, Rui and Pan, Weimin and Lv, Teng},
  title = {Potential Benefits of Statin Therapy in Reducing Osteoarthritis Risk: A Mendelian Randomization Study},
  journal = {Arthritis Care & Research},
  year = {2024},
  doi = {10.1002/acr.25343}
}
Kostenlos starten →